Experimental Veliparib Improves Outcomes for Adv BRCA+ HER2-

Moderators

Have you been diagnosed with advanced-stage HER2-negative breast cancer, but haven't had genetic testing? A study underscores how PARP inhibitors can help treat this type of cancer in people with a BRCA1 or BRCA2 mutation, so it makes sense to talk to your doctor about genetic testing.

Read: Experimental Veliparib Improves Outcomes for People With BRCA Mutation and Advanced-Stage HER2-Negative Breast Cancer